We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




3D Real-Time Ultrasound Cardiac Mapping Technology Improves Accuracy and Patient Safety

By MedImaging staff writers
Posted on 07 Jan 2008
A team of clinicians is the first in the United States to utilize new ultrasound technology to guide ablation of atrial fibrillation (AF), providing potential improvements in both the precision and safety of this therapy. More...


AF is the most common type of heart rhythm disorder. In treating AF with catheter ablation, cardiac electrophysiologists conventionally use standard X-ray technology to guide proper placement of radiofrequency energy to ablate the tissues (cause small areas of scarring) in the heart responsible for starting and maintaining the irregular rhythm. The clinicians, from Loyola University Health System (Maywood, IL, USA), also can generate a computer reconstruction of the heart's interior, frequently with the help of images obtained from either computed tomography (CT) or magnetic resonance imaging (MRI) scans done before the procedure. While helpful, these reconstructions can be time-consuming, difficult to produce, and expose patients to additional radiation.

With newly installed software imaging technology, the CartoSound image integration module and SoundStar 3D catheter, Loyola physicians now are able to visualize and create a whole new kind of map of the heart in order to perform atrial ablation. They use ultrasound imaging to produce images of the heart during the ablation procedure. The ultrasound technique produces three-dimensional (3D) images of the heart's anatomy within a few minutes at the bedside, and allows real-time, simultaneous monitoring of catheter position and orientation during the procedure, improving both precision and patient safety. Dr. David Wilber, professor of cardiovascular sciences at Loyola University Stritch School of Medicine, reported that he and his team have used the new technology with 20 patients giving "excellent results.” The technology was developed by Biosense Webster, Inc.(Diamond Bar, CA, USA), a Johnson & Johnson company.

Whereas the previous method provided 3D images of the heart, they frequently lacked sufficient detail. Incorporating CT images from a scan obtained several days earlier provided more detail, but it was difficult to accurately register the older image to the precise orientation of the heart during the procedure.

"The new 3D ultrasound images provide a very detailed view of the heart, and most importantly, they reflect the condition of the heart during the procedure. Since the image is generated by the same computer program that tracks the location of the catheter, the points of interest match very closely,” Dr Wilber explained. "This allows very accurate placement of lesions [the scarring] to assure elimination of the arrhythmia, while avoiding injury to important nearby structures, such as the pulmonary veins or the esophagus. We can now image these structures with unprecedented accuracy continuously during the procedure.”

Overall procedure time is decreased by more than 30 minutes, Dr. Wilber added, and the need for additional imaging procedures prior to ablation may be completely eliminated. "This is real breakthrough in making these procedures safer, more precise, and less taxing on the patient. We are extremely excited about being able to bring these benefits to patients here at Loyola,” Dr. Wilber said.

AF may be related to coronary artery disease, thyroid disease, high blood pressure, or other structural heart defects, but frequently has no detectable cause. If left untreated, AF can cause structural heart changes that diminish heart function.


Related Links:
Biosense Webster
Loyola University Health System

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.